Those who take oral hormone replacement therapy (HRT) should also have a conversation with their care provider about how GLP-1s may impact the effectiveness of those medications
Data Validation and Update Cycle: Findings are validated by comparing primary interviews with public data, company activity, regulatory changes, trade patterns, and industry developments
Programs that combine licensed provider oversight with GLP-1 medications and lifestyle support are now accessible from your phone, no waiting room required
The authors have given talks and attended conferences sponsored by various pharmaceutical companies, including Bristol-Myers Squibb, Pfizer, Lilly, Abbott, Amgen, Astrazeneca, Novartis, Vianex, Teva, and MSD